Close

Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company

Go back to Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company

Guardant Health (GH) Said to Decide Against NeoGenomics (NEO) Takeover - Bloomberg

October 4, 2021 6:16 AM EDT

Guardant Health (NASDAQ: GH) had decided not to pursue a potential acquisition of NeoGenomics (NASDAQ: NEO), according to Bloomberg, citing people familiar with the matter. It decided against the deal over the weekend.

Shares in Guardant have fallen nearly 20% since talks began.

... More

Guardant Health's (GH) Potential Deal for NeoGenomics (NEO) Would Be Dilutive to Top Line - Stifel

October 1, 2021 12:57 PM EDT

Stifel analyst Daniel Arias weighs in on speculation Guardant Health (NASDAQ: GH) is looking to acquire NeoGenomics (NASDAQ: NEO).

Arias said the deal would be dilutive to GH's top-line. He commented: "... we have GH growing 40% in... More

Increasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD

October 1, 2021 10:12 AM EDT

Increasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD

... More

Increasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD

October 1, 2021 10:01 AM EDT

Increasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD

... More

Pre-Open Stock Movers 10/01: (NEO) (SPWR) (MRK) Higher; (OMER) (IRNT) Lower (more...)

October 1, 2021 9:27 AM EDT

Pre-Open Stock Movers:

Omeros Corporation (Nasdaq: OMER) 30% LOWER; announced that the U.S. Food and Drug Administration (FDA) notified the company that, as part of FDAs ongoing review of the companys Biologics License Application (BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), FDA has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time. FDA stated that the notification does not reflect a final decision on the information under review.

IronNet (NYSE:... More

Guardant Health (GH) Said to Weigh Takeover of NeoGenomics (NEO) - Bloomberg

October 1, 2021 9:03 AM EDT

(Updated - October 1, 2021 9:05 AM EDT)

Guardant Health (NASDAQ: GH) is exploring an acquisition of NeoGenomics (NASDAQ: NEO), according to Bloomberg, citing people familiar with the matter.

The companies have held talks about a potential deal, and deliberations are ongoing.

... More